The direct antiplasmodial effects of five structurally-related flavonoids, namely quercetin, rutin, eriodictyol, eriodictyolchalcone and catechin, were analyzed in vitro on P. falciparum. Notably, all these flavonoids, with the only exception of rutin, caused relevant inhibition of P. falciparum growth when given at 1 mM concentration. In addition, they were found to affect greatly the potent antiplasmodial activity of artemisinin, leading to significant additive and even synergistic effects. In particular, quercetin induced a pronounced synergistic effect. The observed synergisms might be conveniently exploited to design new and/or more effective combination therapies.
Artemisinin, a sesquiterpene endoperoxide isolated from Artemisia annua L., is today a leading drug for the treatment of malaria. It is very effective against severe forms of malaria and, in particular, against chloroquine-resistant, primaquine-resistant and some other life-threatening forms of malaria. It is a drug of high efficacy and rapid action, with a good tolerability, leading to clearance of parasites from the blood within two days [1] .
Artemisinin and its semi-synthetic derivatives induce a very rapid reduction of parasitaemia, starting almost immediately after administration and are potent blood schizontocides [2] . These compounds are also gametocytocidal [3] and, interestingly, block the early sexual-stage (gametocyte) development [4, 5] , but they do not kill the hepatic stages of the parasite. In addition, they inhibit important pathophysiological processes, such as cytoadherence of Plasmodium falciparum-infected erythrocytes to microvasculature, more effectively than other antimalarial drug classes [6] .
The mechanism of action of artemisinin and its derivatives is still a matter of intense debate [7, 8] . Their activity is strictly associated to the presence of a unique structural feature, the endoperoxide bridge; their primary target, however, is yet not known. Meunier and coworkers demonstrated that heme is alkylated by artemisinin in meso positions and an extensive characterization of such adducts was carried out accordingly [9] [10] [11] . Heme alkylation was recently shown to occur also in vivo [12] . Similar heme adducts are formed in vitro with some derivatives of artemisinin, as found in our previous investigation [13] . A significant reactivity of artemisinin with hemoglobin has been described as well [14] . However, more recently, it was proposed that artemisinin and its derivatives most likely act through a mechanism similar to thapsigargin. This latter drug potently inhibits PfATP6, a key parasite Ca 2+ transporter with a particular selectivity for the SERCA of malarial PfATP6 rather than for mammalian pumps [15] .
Due to the evident lack of conclusive ideas concerning the mechanism of action, together with the fact that artemisinin kills parasites rapidly, but is also rapidly excreted, the WHO Expert Consultative Group in 2001 strongly recommended the development of combination therapies since such drug associations have the potential to reduce the appearance of resistance and to be more effective in eradicating malaria [16] .
Within the frame of a larger research project aimed at evaluating the possible synergism/antagonism of antimalarial drugs with a variety of widespread natural products, we have recently shown that green tea extracts, as well as their main catechin constituents, markedly inhibit P. falciparum growth in vitro and potentiate the antimalarial effects of artemisinin [17] . These results are nicely consistent with the concept that complex mixtures of artemisinin with other natural products, as those that are usually found in the crude plant extracts, are often more effective than the purified drug itself. The higher antimalarial potency of the extract compared to the pure drug has thus been ascribed to the concomitant and independent biochemical actions of the other constituents as well as to the occurrence of appreciable synergistic interactions. A number of additional experimental and clinical observations support these ideas.
In view of this background and of the known antimalarial properties of other flavonoids [18] , this article describes the effects against P. falciparum 3D7 strain, sensitive to chloroquine, of a group of structurally-related flavonoids, namely the flavonol quercetin (2), its diglycoside rutin (3), the flavanone eriodictyol (4), the chalcone eriodictyolchalcone ((E)-3-(3,4-dihydroxy-phenyl)-1-(2,4,6-trihydroxyphenyl)-propenone) (5) , and catechin (6) . These flavonoids were assayed either alone or in combination with artemisinin.
The first step of our investigation was the evaluation of the effects of the above flavonoids, administered alone, on P. falciparum growth, using two typical and well separated drug concentrations, namely 10 μM and 1 mM, after 48 hours incubation. Growth inhibition was evaluated by a well established enzymatic method based on lactate dehydrogenase activity of P. falciparum (pLDH). Results are reported in Figure 1 . From inspection of Figure 1 , it is evident that all these flavonoids as such, produce rather modest growth inhibition of Plasmodium 3D7 strain, if given at 10 μM concentration. Indeed, only quercetin, eryodictiol and its chalcone produced some measurable effect, causing growth decreases of ~ 5-15% (see Figure 1 ). In contrast, large inhibitory effects were seen when flavonoids were given at 1 mM concentration. In this latter case, eryodictiol chalcone and catechin turned out to be the most active with 88% and 86% inhibition, respectively. Using the same 1 mM concentration, eryodictiol caused 68% inhibition and quercetin 51% inhibition. In contrast, rutin, the diglycoside of quercetin, had only a modest activity causing just 10% inhibition. It is well known that these substances are usually safe and that their concentrations in many plant extracts may be very high; this observation implies that even relatively moderate antimalarial activities, such as those reported above, may have, nonetheless, important practical consequences.
Afterwards, possible synergism between artemisinin and the single flavonoid constituents 2-6 on parasite growth was investigated by monitoring artemisinin effects in the presence (or in the absence) of either 10 µM or 1 mM concentrations of the individual compounds. In this second set of experiments, ART concentration ranged between 0.625 to 40 nM, as administration of such concentrations resulted in partial inhibition of P. falciparum growth (Figure 2) . Notably, we found that the effects of artemisinin, given at different concentrations, and 10 µM quercetin are more than additive; this effect becomes still more evident when quercetin was tested at 1 mM concentration, implying some significant synergism between these two substances. The largest synergistic effects are detected for (sublethal) ART doses ranging from 0.625 to 10 nM (Figure 2) . The other flavonoids did not show evident synergistic effects; however, sizable additive effects were found when eriodictyol and eriodictyolchalchone 1 mM were added to 5, 2.5, 1.25 and 0.625 nM of artemisinin. These flavonoids at 10 μM concentrations did not show additive effects.
Overall, the results reported above point out that the intrinsic antiplasmodial activities of the five tested flavonoids are rather moderate or even modest. However, they cannot be neglected in view of the usually high concentrations of these substances in plant extracts and of their safety. In addition, we have shown that all these flavonoids generally manifest additive effects with artemisinin, leading to a substantial potentiation of its antimalarial actions. Most remarkably, considerable synergism was found in the case of quercetin. This latter finding is not surprising as quercetin is known to be an inhibitor of thioredoxin reductase and a prooxidant [19] . As artemisinin is thought to work through induction of oxidative stress on P. falciparum, the observed synergism might be straightforwardly ascribed to exacerbation of oxidative stress caused by quercetin.
In particular, the observed synergism between quercetin and artemisinin might be conveniently exploited to design new and/or more effective combination therapies. Moreover, we believe that valuable mechanistic information on the individual antimalarial agents may be extracted from a careful comparative analysis of the established positive and negative drug-drug interactions [20] .
Experimental
Reagents: Artemisinin was obtained from Sigma (Milan, Italy). Flavonoids 2-6 were from Extrasynthese (Genay, France).
Parasite maintenance: Cultures of P. falciparum, 3D7 drug-sensitive to chloroquine (CQR), were grown in vitro in human red blood cells (O + ), as formerly described [21] .
In vitro determination of antimalarial activity of flavonoids:
The selected flavonoids were prepared as stock solutions in 95% ethanol and then diluted in complete RPMI medium (containing 10% human serum). In all tests, the concentration of ethanol was maintained at 0.02% and did not inhibit the growth of control cultures. The individual flavonoids were presented at concentrations of 10 μM and 1 mM. Growth inhibition was evaluated by a well established enzymatic method based on lactate dehydrogenase activity of P. falciparum (pLDH) [22] . The parasite strain of P. falciparum, 3D7 drugsensitive to chloroquine, was used for the in vitro tests after culture syncronization by sorbitol [23] .
The effects of flavonoids on cultured parasites were determined by light microscopy and pLDH activity, as previously described in detail [24] . Each assay was performed in triplicate, on 3 separate occasions.
Monitoring flavonoid modulation of artemisinin activity: P. falciparum growth inhibition was analysed as a function of added artemisinin, at sublethal doses, ranging from 0.625 to 40 nM, either in the presence or absence of either 10 μM or 1 mM of the flavonoid constituents.
